Participation of Kazakhstan Pharmaceutical Companies in Global Value Chains

Authors

  • Elena D. Frolova Ural Federal University
  • Zulparuza A. Abdurahkmanova Karaganda Economic University of Kazpotrebsoyuz
  • Alexander A. Ishukov Ural Federal University; Institute of Economics of the Ural Branch of RAS

DOI:

https://doi.org/10.17059/ekon.reg.2021-2-9

Keywords:

pharmaceutical companies, global value chains (GVCs), value added configuration, GVC analysis, enterprise participation in GVCs, enterprise level, analysis of GVC participation, backward participation, generic drugs, pioneering entry into GVCs, Republic of Kazakhstan

Abstract

Growing interest of national economies in global value chains (GVCs) and the lack of micro-level research brought us to study the integration of countries in GVCs at the enterprise level (using the example of the pharmaceutical industry). We examine the situation in the Republic of Kazakhstan that is beginning to integrate into GVCs. Results of a questionnaire survey of the country’s pharmaceutical companies are considered along with public statistics. We developed a methodology to analyse the participation of a national entity in GVCs at the micro-level (including the enterprise participation in GVCs) and assess the performance of Kazakh pharmaceutical companies. The research is based on export and import data. A hypothesis on the participation of national pharmaceutical enterprises was partially confirmed: several surveyed companies participate in generic drugs GVCs at the production level, thus the value added is low. Features of pioneering entry into pharmaceutical global value chains for countries lacking such integration experience were demonstrated on a specific example. The obtained results can be used by countries starting the process of integration into pharmaceutical GVCs, as well as by Kazakhstan when developing the pharmaceutical industry.

Author Biographies

Elena D. Frolova, Ural Federal University

Dr. Sci. (Econ.), Professor, Academic Department of International Economics and Management

Zulparuza A. Abdurahkmanova, Karaganda Economic University of Kazpotrebsoyuz

Master (Econ.), Senior Lecturer, Faculty of Business and Law

Alexander A. Ishukov, Ural Federal University; Institute of Economics of the Ural Branch of RAS

Senior Lecturer, Academic Department of International Economics and Management; Economist

References

Meshkova, T. & Moiseichev E. (2016). Foresight Applications to the Analysis of Global Value Chains. Forsait [Foresight and STI Governance], 10(1), 69–82. Retrieved from: https://foresight-journal.hse.ru/data/2017/06/14/1170591870/6-Мешкова-69–82.pdf (Date of access: 10.08.2020) DOI: 10.17323/1995–459x.2016.1.69.82. (In Russ.)

Kondrat’ev, V. B. (2015). World economy as global value chain’s network. Mirovaya ekonomika i mezhdunarodnye otnosheniya [World Economy and International Relations], 3, 5–17. (In Russ.)

Kaukin, A. S. & Idrisov, G. (2013). The Gravity Model of Russian Foreign Trade: Case of a Country with Large Area and Long Border. Ekonomika i Politika [Economics and Politics], 4, 133–154. Retrieved from: https://www.iep.ru/files/text/policy/2013–4/kaukin.pdf (Date of access: 10.08.2020) (In Russ.)

Wadhwa, V., Rissing, B., Gereffi, G., Trumpbour, J. & Engardio, P. (2008). The globalization and innovation: Pharmaceuticals: Can India and Chine Cure the Global Pharmaceutical Market. Durham: Duke university, 67. Retrieved from: http://ssrn.com/abstract=1143472 (Date of access: 31.07. 2020)

Elms, D. K. & Low, P. (2013). Global value chains in a changing world. Switzerland: Global Institute, Nanyang Technological University, and World Trade Organization, 436. Retrieved from: http://www.cggc.duke.edu/pdfs/2013–07_Elms&Low_eds_GlobalValueChains_in_a_ChangingWorld_WTO.pdf (Date of access: 20.12.2020).

Sapir, E. V., Karachyov, I. A. & Zhang, M. (2016). Russian Pharmaceutical Companies Export Potential in Emerging Regional Clusters. Ekonomika regiona [Economy of region], 12(4), 1194–1204. DOI: 10.17059/2016–4–20. (In Russ.)

Andreeva, E. L., Sapir, E. V., Karkh, D. A. & Karachev, I. A. (2019). Comparative Analysis of Foreign Economic Development of Pharmaceutical Sector in Russia and the USA. Ekonomika regiona [Economy of region], 15(2), 576–589. DOI: 10.17059/2019–2-20. (In Russ.)

Sidorova, E. A. (2018). Russia in global value chains. Mirovaya ekonomika i mezhdunarodnye otnosheniya [World Economy and International Relations], 62(9), 71–80. DOI: 10.20542/0131–2227–2018–62–9-71–80. (In Russ.)

Klochko, O. & Manuylov, I. (2019). Canadian pharmaceutical industry in global value chains: Influence of dominant trading partner. Mirovaya ekonomika i mezhdunarodnye otnosheniya [World Economy and International Relations], 63(4), 14–21. DOI: 10.20542/0131–2227–2019–63–4-14–21. (In Russ.)

Andreev, P. S. (2017). Methods of performance evaluation of Russia’s participation in GVC and the forming of effective value chains involving Asia-Pacific countries. Vestnik RUDN. Seriya: Ekonomika [RUDN Journal of Economics], 25(1), 28–40. DOI: 10.22363/2313–2329–2017–25–1-28–40. (In Russ.)

Danilchenko, A. V., Bertosh, E. V. & Malashenkova, O. F. (2015). Internatsionalizatsiya delovoy aktivnosti stran i kompaniy [Internationalization of countries and companies business activity]. Minsk: BSU, 295. (In Russ.)

Frolova, E. & Shishmintsev, M. (2015). Development of the new forms of business internationalization in global geoeconomic space. In: Proceedings of the 8th EuroMed Conference of the EuroMed Academy of Business (pp. 610–623). EuroMed.

Kochetov, E. G. (2006). Geoekonomicheskiy (globalnyy) tolkovyy slovar. Sbornik strategicheskikh ponyatiy-novell [Geoeconomics (global) explanatory dictionary]. Ekaterinburg: Uralskiy rabochiy, 504. (In Russ.)

Gereffi, G. & Fernandez-Stark, K. (2016). Global Value Chain Analysis: A PRIMER, 2-nd edition. Duke University. Retrieved from: https://www.researchgate.net/publication/305719326_Global_Value_Chain_Analysis_A_Primer_2nd_Edition (Date of access: 31.08.2020).

Volgina, N. A. (2017). Cross-border value chains: historical approaches and modern concepts. In: L. S. Revenko (Ed.), Mezhdunarodnye ekonomicheskie otnosheniya: plyuralizm mneniy v epokhu peremen: kol. monografiya [International economic relations: pluralism of opinions in an era of change: Collective Monography] (pp. 422–428). Moscow: MGIMO-Universitet. (InRuss.)

Pisareva, S. S. & Volgina, N. A. (2018). Tsepochki stoimosti v avtomobilestroenii stran TSentralnoy i Vostochnoy Evropy: opyt dlya Rossii [Automotive Value Chains in Central and Eastern Europe: Experience for Russia]. Moscow: KNORUS, 184. (In Russ.)

Luk’yanov, S. A. & Drapkin, I. M. (2017). Global value chains: effects for integrating economy. Mirovaya ekonomika i mezhdunarodnye otnosheniya [World Economy and International Relations], 4, 16–25. (In Russ.)

Shamray, L. V. & Ledeneva, M. V. (2015). Global added value chains in the global reproduction process. Biznes. Obrazovanie. Pravo. Vestnik Volgogradskogo instituta biznesa [Business. Education. Law. Bulletin of the Volgograd Business institute], 3(32), 114–120. (In Russ.)

Zhang, Y., Li, D., Yang, C. & Du, Q. (2010). On the Value Chain and International Specialization of China’s Pharmaceutical Industry. Journal of International Commerce and Economics, 81–107. Retrieved from: https://www.usitc.gov/journals/04_ZhangLiYangDu_ValueChainPharma.pdf (Date of access: 21.12.2020).

Egeraat, C. van & Barry, F. (2008). The Irish Pharmaceutical Industry over the Boom Period and Beyond. NIRSA Working Paper Series, 39, 26. Retrieved from: https://www.maynoothuniversity.ie/sites/default/files/assets/document/39vanegeraatandbarry_0_0.pdf (Date of access: 11.11.2020).

Akhtanova, M. D. & Tamenova, S. S. (2019). Participation of Kazakhstan in global value chains. Vestnik universiteta «Turan [Bulletin of «Turan» University], 3(83), 196–200. (In Russ.)

OECD. (2018). Economic Reform Programme: Diagnostic Tool For Identifying Key Constraints to Competitiveness. OECD, 88. Retrieved from: https://www.oecd.org/south-east-europe/programme/ERP_Diagnostic_Tool.pdf (Date of access: 31.07.2020).

Madiyarova, E. S. (2011). The state and prospects for the development of the pharmaceutical industry in the Republic of Kazakhstan. Vestnik KASU [KAFU Academic Journal], 3. Retrieved from: http://www.vestnik-kafu.info/journal/29/1194/ (Date of access: 10.08.2020) (In Russ.)

Guskov, V. & Marzilovich, O. (2008). Sostoyanie i prognoz razvitiya farmacevticheskogo rinka Kazahstana [State and forecast of development of the pharmaceutical market in Kazakhstan]. Almaty: BTA Analitika, 43. Retrieved from: http://bta.kz/files/9-farma_main.pdf (Date of access: 10.08.2020) (In Russ.)

Frolova, E. D & Abdurahmanova, Z. A. (2016). Internationalization Activity Models of Modern Pharmaceutical Companies Activity. Ekonomika i predprinimatelstvo [Journal of Economy and entrepreneurship], 12–1(77–1), 1007–1011. (In Russ.)

Huttin, C. (2020). Global value chains and international pharmaceutical policy. Technology and health care: official journal of the European Society for Engineering and Medicine, 28(2), 337–344. Retrieved from: https://www.pubfacts.com/detail/32280074/Global-value-chains-and-international-pharmaceutical-policy (Date of access: 21.12.2020). DOI: 10.3233/THC-192103.

Published

24.06.2021

How to Cite

Frolova, E. D., Abdurahkmanova, Z. A., & Ishukov, A. A. (2021). Participation of Kazakhstan Pharmaceutical Companies in Global Value Chains. Economy of Regions, 17(2), 473–485. https://doi.org/10.17059/ekon.reg.2021-2-9

Issue

Section

Research articles